The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Intravenous Brain-Derived Neurotrophic Factor Reduces Infarct Size and Counterregulates Bax and Bcl-2 Expression After Temporary Focal Cerebral Ischemia
Abstract
Background and Purpose —Pretreatment with intraventricular brain-derived neurotrophic factor (BDNF) reduces ischemic damage after focal cerebral ischemia. In this experiment we studied the effect of intravenous BDNF delivered after focal cerebral ischemia on neurological outcome, infarct size, and expression of proapoptotic and antiapoptotic proteins Bax and Bcl-2, respectively. Methods —With the use of the suture occlusion technique, the right middle cerebral artery in rats was temporarily occluded for 2 hours. Thirty minutes after vessel occlusion, BDNF (300 μg/kg per hour in vehicle; n=12) or vehicle alone (n=13) was continuously infused intravenously for 3 hours. After 24 hours the animals were weighed and neurologically assessed on a 5-point scale. The animals were then killed, and brains underwent either 2,3,5-triphenyltetrazolium chloride staining for assessment of infarct volume or paraffin embedding for morphology and immunohistochemistry (Bax, Bcl-2). Results —Physiological parameters (mean arterial blood pressure, P o 2 , P co 2 , pH, body temperature, glucose) and weight revealed no difference between groups. Neurological deficit was improved in BDNF-treated animals versus controls ( P <0.05, unpaired, 2-tailed t test). Mean±SD infarct volume was 229.7±97.7 mm 3 in controls and 121.3±80.2 mm 3 in BDNF-treated animals ( P <0.05, unpaired, 2-tailed t test). Cortical infarct volume was 155.5±78.5 mm 3 in the placebo group and 69.9±50.2 mm 3 in the BDNF-treated group ( P <0.05, unpaired, 2-tailed t test). Subcortical infarct volume was 74.1±30.6 mm 3 in the placebo group and 51.1±26.8 mm 3 in the BDNF-treated group ( P =NS). Bax-positive neurons were significantly reduced in the ischemic penumbra in BDNF-treated animals ( P <0.05, unpaired, 2-tailed t test), whereas Bcl-2–positive neurons were significantly increased in this area ( P <0.001, unpaired, 2-tailed t test). Conclusions —This study demonstrates a neuroprotective effect of BDNF when delivered intravenously after onset of focal cerebral ischemia. As shown here, one possible mechanism of action of neuroprotection of BDNF after focal ischemia appears to be counterregulation of Bax/Bcl-2 proteins within the ischemic penumbra.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
(1982) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 51,963
Reversible middle cerebral artery occlusion without craniectomy in rats.
Longa, E. Z., Weinstein, P. R., Carlson, S., & Cummins, R. (1989) · Stroke · doi:10.1161/01.str.20.1.84 · Cited by 7,463
BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra
Hyman, C., Hofer, M., Barde, Y.-A., Juhasz, M., Yancopoulos, G. D., Squinto, S. P., & Lindsay, R. M. (1991) · Nature · doi:10.1038/350230a0 · Cited by 1,494
The trk Proto-Oncogene Product: a Signal Transducing Receptor for Nerve Growth Factor
Kaplan, D. R., Hempstead, B. L., Martin-Zanca, D., Chao, M. V., & Parada, L. F. (1991) · Science · doi:10.1126/science.1850549 · Cited by 1,379
Transport of brain-derived neurotrophic factor across the blood–brain barrier
Pan, W., Banks, W. A., Fasold, M. B., Bluth, J., & Kastin, A. J. (1998) · Neuropharmacology · doi:10.1016/s0028-3908(98)00141-5 · Cited by 1,354
Hohn, A., Leibrock, J., Bailey, K., & Barde, Y.-A. (1990) · Nature · doi:10.1038/344339a0 · Cited by 1,145
trkC, a new member of the trk family of tyrosine protein kinases, is a receptor for neurotrophin-3
Lamballe, F., Klein, R., & Barbacid, M. (1991) · Cell · doi:10.1016/0092-8674(91)90442-2 · Cited by 1,080
Mediation by a CREB Family Transcription Factor of NGF-Dependent Survival of Sympathetic Neurons
Riccio, A., Ahn, S., Davenport, C. M., Blendy, J. A., & Ginty, D. D. (1999) · Science · doi:10.1126/science.286.5448.2358 · Cited by 802
Sendtner, M., Holtmann, B., Kolbeck, R., Thoenen, H., & Barde, Y.-A. (1992) · Nature · doi:10.1038/360757a0 · Cited by 707
Ernfors, P., Ibáñez, C. F., Ebendal, T., Olson, L., & Persson, H. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.14.5454 · Cited by 700
Cited by
Molecular targets in cerebral ischemia for developing novel therapeutics
Mehta, S. L., Manhas, N., & Raghubir, R. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2006.11.003 · Cited by 708
A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone
Jang, S.-W., Liu, X., Yepes, M., Shepherd, K. R., Miller, G. W., Liu, Y., Wilson, W. D., Xiao, G., Blanchi, B., Sun, Y. E., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913572107 · Cited by 686
Almeida, R. D., Manadas, B. J., Melo, C. V., Gomes, J. R., Mendes, C. S., Grãos, M. M., Carvalho, R. F., Carvalho, A. P., & Duarte, C. B. (2005) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401662 · Cited by 583
Exercise plasma boosts memory and dampens brain inflammation via clusterin
De Miguel, Z., Khoury, N., Betley, M. J., Lehallier, B., Willoughby, D., Olsson, N., Yang, A. C., Hahn, O., Lu, N., Vest, R. T., et al. (2021) · Nature · doi:10.1038/s41586-021-04183-x · Cited by 422
Schäbitz, W.-R., Steigleder, T., Cooper-Kuhn, C. M., Schwab, S., Sommer, C., Schneider, A., & Kuhn, H. G. (2007) · Stroke · doi:10.1161/strokeaha.106.477331 · Cited by 441
Self-citationEarly Rehabilitation After Stroke: a Narrative Review
Coleman, E. R., Moudgal, R., Lang, K., Hyacinth, H. I., Awosika, O. O., Kissela, B. M., & Feng, W. (2017) · Current Atherosclerosis Reports · doi:10.1007/s11883-017-0686-6 · Cited by 424
Duan, W., Guo, Z., Jiang, H., Ware, M., Li, X.-J., & Mattson, M. P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0536856100 · Cited by 428
Vaynman, S., & Gomez-Pinilla, F. (2005) · Neurorehabilitation and Neural Repair · doi:10.1177/1545968305280753 · Cited by 420
Neuroprotective Effect of Granulocyte Colony–Stimulating Factor After Focal Cerebral Ischemia
Schäbitz, W.-R., Kollmar, R., Schwaninger, M., Juettler, E., Bardutzky, J., Schölzke, M. N., Sommer, C., & Schwab, S. (2003) · Stroke · doi:10.1161/01.str.0000057814.70180.17 · Cited by 409
Self-citationKurozumi, K., Nakamura, K., Tamiya, T., Kawano, Y., Ishii, K., Kobune, M., Hirai, S., Uchida, H., Sasaki, K., Ito, Y., et al. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2004.09.020 · Cited by 398
The MPTP model of Parkinson's disease
Smeyne, R. J., & Jackson-Lewis, V. (2005) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.09.017 · Cited by 377
Kurozumi, K., Nakamura, K., Tamiya, T., Kawano, Y., Kobune, M., Hirai, S., Uchida, H., Sasaki, K., Ito, Y., Kato, K., et al. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2003.10.012 · Cited by 339
Schäbitz, W.-R., Berger, C., Kollmar, R., Seitz, M., Tanay, E., Kiessling, M., Schwab, S., & Sommer, C. (2004) · Stroke · doi:10.1161/01.str.0000119754.85848.0d · Cited by 283
Self-citationKe, Z., Yip, S. P., Li, L., Zheng, X.-X., & Tong, K.-Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016643 · Cited by 280
Nomura, T., Honmou, O., Harada, K., Houkin, K., Hamada, H., & Kocsis, J. D. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.06.062 · Cited by 258
Wei, X., Du, Z., Zhao, L., Feng, D., Wei, G., He, Y., Tan, J., Lee, W.-H., Hampel, H., Dodel, R., et al. (2009) · Stem Cells · doi:10.1634/stemcells.2008-0333 · Cited by 254
The therapeutic potential of the mesenchymal stem cell secretome in ischaemic stroke
Cunningham, C. J., Redondo-Castro, E., & Allan, S. M. (2018) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x18776802 · Cited by 242
Liu, C., Chan, C. B., & Ye, K. (2016) · Translational Neurodegeneration · doi:10.1186/s40035-015-0048-7 · Cited by 195
Verborgt, O., Tatton, N. A., Majeska, R. J., & Schaffler, M. B. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.5.907 · Cited by 192
Zhang, Y., & Pardridge, W. M. (2001) · Stroke · doi:10.1161/01.str.32.6.1378 · Cited by 175
An Overview of Acute Stroke Therapy: Past, Present, and Future
Fisher, M., & Schaebitz, W. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.21.3196 · Cited by 112
Does PGC1α/FNDC5/BDNF Elicit the Beneficial Effects of Exercise on Neurodegenerative Disorders?
Jodeiri Farshbaf, M., Ghaedi, K., Megraw, T. L., Curtiss, J., Shirani Faradonbeh, M., Vaziri, P., & Nasr-Esfahani, M. H. (2016) · NeuroMolecular Medicine · doi:10.1007/s12017-015-8370-x · Cited by 101
Deoxygedunin, a Natural Product with Potent Neurotrophic Activity in Mice
Jang, S.-W., Liu, X., Chan, C. B., France, S. A., Sayeed, I., Tang, W., Lin, X., Xiao, G., Andero, R., Chang, Q., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011528 · Cited by 101
Qian, M. D., Zhang, J., Tan, X.-Y., Wood, A., Gill, D., & Cho, S. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1118-06.2006 · Cited by 67
“In animal studies, BDNF has been shown to reduce ischemic injury (Schabitz et al., 2000; Kurozumi et al., 2004) and to improve functional recovery and postinjury regeneration (Koda et al.”
BackgroundKim, G. S., Cho, S., Nelson, J. W., Zipfel, G. J., & Han, B. H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088962 · Cited by 27
“This neurotrophic factor prevented neuronal cell death in vivo when given by infusion or virus-mediated delivery [21,22,23,24], and attenuated behavioral deficits following spinal cord injury and ischemic stroke [25,26,27,28].”
Background
Metadata
- Authors
- Schäbitz, W.-R., Sommer, C., Zoder, W., Kiessling, M., Schwaninger, M., & Schwab, S.
- Venue
- Stroke
- Published
- 2000-09
- Volume
- 31
- Issue
- 9
- Pages
- 2212-2217
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W2166346391
- Cited by
- 325
- References
- 48
- FWCI
- 5.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.